Encysive Pharmaceuticals Acquired By Pfizer

Houston-based Encysive Pharmaceuticals was acquired by Pfizer, Pfizer announced Wednesday, in a deal worth approximately $195M in cash. Encysive is a biopharmaceuticals firm developing a treament for pulmonary arterial hypertension (PAH). According to Pfizer, it is making a cash tender offer for all outstanding shares of Encysive for $2.35 per share. Encysive has been looking for a buyer since July of 2007.